Stryker announces robotics alliance; Stryker stock holds steady

Published on 10/25/2026 at 17:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker stock costs EUR 275.05 in weekend trading on October 25, 2026 versus a Xetra close of EUR 275.10. Stryker announced a robotics alliance.

Robotics alliance and upcoming session

Stryker announced a strategic robotics alliance with a preferred equity investment of approximately USD 400 million on October 12, 2026.
Stryker stock trades in weekend trading at Lang & Schwarz at EUR 275.05 on October 25, 2026, 0.02 percent below the Xetra close of October 23, 2026.
The next Xetra session is scheduled for October 26, 2026.
Stryker reported FDA clearance for Sonopet 3 on October 14, 2026.

Schwarzweiß-Dokumentarfoto von Klinikpersonal mit sterilem Instrumentenwagen im Flur — Schwarzweiß-Reportagefoto zeigt Klinikpersonal mit Instrumentenwagen, passend zu Stryker Corp. US8636671013 im Medizintechnik-Sektor, Illustration mit AI erstellt.

On October 12, 2026, Stryker announced a strategic alliance with CMR Surgical that includes an approximately USD 400 million preferred equity investment and an option to acquire CMR Surgical’s remaining equity. The company also agreed to serve as the exclusive U.S. sales agent for CMR Surgical’s Versius surgical robotics portfolio, according to Stryker.

At 5:33 p.m. CEST on October 25, 2026, the stock was at EUR 275.05 in weekend trading at Lang & Schwarz, 0.02 percent below the Xetra close of EUR 275.10 on October 23, 2026.

Weekend trading

Lang & Schwarz showed a bid of EUR 274.50 and an ask of EUR 275.60 at 5:33 p.m. CEST on October 25, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Stryker stock.

The week in figures

The Xetra close on October 23, 2026 was EUR 275.10. The October 25, 2026 weekend-trading price at Lang & Schwarz was EUR 275.05, a difference of 0.02 percent below that reference.

Chronology of the week

On October 12, 2026, Stryker announced the CMR Surgical alliance and the approximately USD 400 million preferred equity investment. On October 14, 2026, Stryker said the U.S. Food and Drug Administration had granted 510(k) clearance for Sonopet 3, its latest ultrasonic bone and soft-tissue removal platform, according to Stryker.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. Stryker’s third-quarter 2026 results are scheduled for October 29, 2026, according to the company’s investor-relations announcement.

Market context: Market report S&P 500.